HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
AG 013925
a VEGFR2 kinase inhibitor
Also Known As:
AG-013925; AG013925
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Pyrazoles: 61
Indazoles: 179
AG 013925: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Indazoles: 179
AG 013925: 1
Experts
1.
Bogdanov, Alexei
: 1 article (09/2005)
2.
Hu-Lowe, Dana
: 1 article (09/2005)
3.
Reichardt, Wilfried
: 1 article (09/2005)
4.
Torres, Denise
: 1 article (09/2005)
5.
Weissleder, Ralph
: 1 article (09/2005)
Related Diseases
1.
Neoplasms (Cancer)
09/01/2005 - "
We investigated whether antiangiogenic tumor responses induced by an experimental VEGFR-TKI (AG013925; Pfizer Global Research and Development) could be reported by magnetic resonance imaging (MRI) during the initial phase of treatment.
"